Geneva, 15 October 2009 - For this year's European Development Days, to be held in Stockholm from 22-24 October, the GAVI Alliance will be co-organising a debate on global health - together with the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, UNAIDS, the Stop AIDS Alliance, and AIDS Accountability International.
High-level representatives from all five organisations will be discussing the challenges of funding for global health in times of crisis. The key question for the debate will be: "Can the Health MDGs still be met in times of crisis?"
Panelists are Michel Kazatchkine, Executive Director of the Global Fund, Michel Sidibé, Executive Director of UNAIDS, and Joelle Tanguy, GAVI's Managing Director for External Relations, among others. The governments of Sweden and Spain, as well as the European Commission will also send high-level representatives to the panel.
Emphasis will be placed by all stakeholders on the necessity to reinforce commitments on health despite the current economic slowdown.
A focus of the debate will be the need for more accountability and to ensure an integrated approach to health as a constructive way forward.
More than 70 per cent of GAVI's support for immunisation and health programmes goes to African, Caribbean and Pacific countries (ACP). Since 2003, the European Commission has committed a total of up to € 53 million to support introduction of new and underused vaccines and reduce child mortality in ACP countries.
The ACP Committee of Ambassadors this year approved an additional € 20 million from the 10th EDF Intra-ACP Development Cooperation Funds to ensure that children in ACP countries continue to receive life-saving vaccines in 2010 and 2011.
GAVI's funds also come from a number of EU member states including Denmark, France, Germany, Ireland, Italy, Luxembourg, the Netherlands, Spain, Sweden and the UK.
The commitment of the European Commission and EU member states has helped GAVI immunise millions of children. WHO estimates that by the end of 2008 GAVI-funded programmes have averted 3.4 million premature deaths.